{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:33:01Z","timestamp":1791311581536,"version":"4.3.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T00:00:00Z","timestamp":1341446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10143-012-0401-6","type":"journal-article","created":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T21:37:51Z","timestamp":1341783471000},"page":"45-56","source":"Crossref","is-referenced-by-count":51,"title":["Exploratory investigation of eight circulating plasma markers in brain tumor patients"],"prefix":"10.1007","volume":"36","author":[{"given":"Aysegul","family":"Ilhan-Mutlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Widhalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"W\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Czech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heinzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Leutmezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Prayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Marosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Base","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"key":"401_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2990.2007.00854.x","volume":"34","author":"J Attems","year":"2008","unstructured":"Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K (2008) Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Neuropathol Appl Neurobiol 34:23\u201332","journal-title":"Neuropathol Appl Neurobiol"},{"key":"401_CR2","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/cncr.23374","volume":"112","author":"NS Azad","year":"2008","unstructured":"Azad NS, Annunziata CM, Steinberg SM, Minasian L, Premkumar A, Chow C, Kotz HL, Kohn EC (2008) Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy. Cancer 112:1726\u20131732","journal-title":"Cancer"},{"key":"401_CR3","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.2009.26.3988","volume":"28","author":"TT Batchelor","year":"2010","unstructured":"Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK (2010) Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol 28:2817\u20132823","journal-title":"J Clin Oncol"},{"key":"401_CR4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000345258.18071.54","volume":"72","author":"EE Benarroch","year":"2009","unstructured":"Benarroch EE (2009) Neuropeptide Y: its multiple effects in the CNS and potential clinical significance. Neurology 72:1016\u20131020","journal-title":"Neurology"},{"key":"401_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing\u2014when and how? J Clin Epidemiol 54:343\u2013349","journal-title":"J Clin Epidemiol"},{"key":"401_CR6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdf220","volume":"13","author":"A Berglund","year":"2002","unstructured":"Berglund A, Molin D, Larsson A, Einarsson R, Glimelius B (2002) Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma. Ann Oncol 13:1430\u20131437","journal-title":"Ann Oncol"},{"key":"401_CR7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","volume":"7","author":"DJ Brat","year":"2005","unstructured":"Brat DJ, Bellail AC, Van Meir EG (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 7:122\u2013133","journal-title":"Neuro Oncol"},{"key":"401_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1365-2133.2000.03649.x","volume":"143","author":"L Brochez","year":"2000","unstructured":"Brochez L, Naeyaert JM (2000) Serological markers for melanoma. Br J Dermatol 143:256\u2013268","journal-title":"Br J Dermatol"},{"key":"401_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0404.2007.00889.x","volume":"116","author":"T Brommeland","year":"2007","unstructured":"Brommeland T, Rosengren L, Fridlund S, Hennig R, Isaksen V (2007) Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Acta Neurol Scand 116:380\u2013384","journal-title":"Acta Neurol Scand"},{"key":"401_CR10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1535-7163.MCT-04-0208","volume":"4","author":"JG Christensen","year":"2005","unstructured":"Christensen JG, Vincent PW, Klohs WD, Fry DW, Leopold WR, Elliott WL (2005) Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol Cancer Ther 4:938\u2013947","journal-title":"Mol Cancer Ther"},{"key":"401_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0167-0115(84)90064-8","volume":"8","author":"E Ekblad","year":"1984","unstructured":"Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R, Sundler F (1984) Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8:225\u2013235","journal-title":"Regul Pept"},{"key":"401_CR12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1007677003387","volume":"25","author":"LF Eng","year":"2000","unstructured":"Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969\u20132000). Neurochem Res 25:1439\u20131451","journal-title":"Neurochem Res"},{"key":"401_CR13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archpedi.1991.02160110086026","volume":"145","author":"AT Englund","year":"1991","unstructured":"Englund AT, Geffner ME, Nagel RA, Lippe BM, Braunstein GD (1991) Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features. Am J Dis Child 145:1294\u20131297","journal-title":"Am J Dis Child"},{"key":"401_CR14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2009.05.057","volume":"460","author":"ER Frota","year":"2009","unstructured":"Frota ER, Rodrigues DH, Donadi EA, Brum DG, Maciel DR, Teixeira AL (2009) Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. Neurosci Lett 460:130\u2013132","journal-title":"Neurosci Lett"},{"key":"401_CR15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/neuonc\/noq034","volume":"12","author":"W Gartner","year":"2010","unstructured":"Gartner W, Ilhan A, Neziri D, Base W, Weissel M, Wohrer A, Heinzl H, Waldhor T, Wagner L, Preusser M (2010) Elevated blood markers 1\u00a0year before manifestation of malignant glioma. Neuro Oncol 12:1004\u20131008","journal-title":"Neuro Oncol"},{"key":"401_CR16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/cercor\/11.12.1161","volume":"11","author":"W Gartner","year":"2001","unstructured":"Gartner W, Lang W, Leutmetzer F, Domanovits H, Waldhausl W, Wagner L (2001) Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca(2+)-binding protein. Cereb Cortex 11:1161\u20131169","journal-title":"Cereb Cortex"},{"key":"401_CR17","first-page":"453","volume":"39","author":"K Hamaya","year":"1985","unstructured":"Hamaya K, Doi K, Tanaka T, Nishimoto A (1985) The determination of glial fibrillary acidic protein for the diagnosis and histogenetic study of central nervous system tumors: a study of 152 cases. Acta Med Okayama 39:453\u2013462","journal-title":"Acta Med Okayama"},{"key":"401_CR18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jlb.56.5.559","volume":"56","author":"A Harada","year":"1994","unstructured":"Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56:559\u2013564","journal-title":"J Leukoc Biol"},{"key":"401_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361\u2013387","journal-title":"Stat Med"},{"key":"401_CR20","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New York"},{"key":"401_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.05.028","volume":"178","author":"Y Hu","year":"2007","unstructured":"Hu Y, Wang YD, Guo T, Wei WN, Sun CY, Zhang L, Huang J (2007) Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma. Cancer Genet Cytogenet 178:1\u201310","journal-title":"Cancer Genet Cytogenet"},{"key":"401_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0361-9230(99)00005-2","volume":"48","author":"SE Ilyin","year":"1999","unstructured":"Ilyin SE, Gayle D, Gonzalez-Gomez I, Miele ME, Plata-Salaman CR (1999) Brain tumor development in rats is associated with changes in central nervous system cytokine and neuropeptide systems. Brain Res Bull 48:363\u2013373","journal-title":"Brain Res Bull"},{"key":"401_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(78)90107-7","volume":"35","author":"CM Jacque","year":"1978","unstructured":"Jacque CM, Vinner C, Kujas M, Raoul M, Racadot J, Baumann NA (1978) Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J Neurol Sci 35:147\u2013155","journal-title":"J Neurol Sci"},{"key":"401_CR24","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awm263","volume":"130","author":"CS Jung","year":"2007","unstructured":"Jung CS, Foerch C, Schanzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M (2007) Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain 130:3336\u20133341","journal-title":"Brain"},{"key":"401_CR25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/NEN.0b013e318180e618","volume":"67","author":"M Korner","year":"2008","unstructured":"Korner M, Reubi JC (2008) Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors. J Neuropathol Exp Neurol 67:741\u2013749","journal-title":"J Neuropathol Exp Neurol"},{"key":"401_CR26","doi-asserted-by":"crossref","first-page":"E1335","DOI":"10.1152\/ajpendo.00333.2007","volume":"293","author":"K Kos","year":"2007","unstructured":"Kos K, Harte AL, James S, Snead DR, O'Hare JP, McTernan PG, Kumar S (2007) Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am J Physiol Endocrinol Metab 293:E1335\u20131340","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"401_CR27","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.27.8.1304","volume":"27","author":"RU Kothari","year":"1996","unstructured":"Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304\u20131305","journal-title":"Stroke"},{"key":"401_CR28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"401_CR29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jnr.10253","volume":"69","author":"YB Lee","year":"2002","unstructured":"Lee YB, Nagai A, Kim SU (2002) Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69:94\u2013103","journal-title":"J Neurosci Res"},{"key":"401_CR30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","volume":"260","author":"LF Lin","year":"1993","unstructured":"Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130\u20131132","journal-title":"Science"},{"key":"401_CR31","volume-title":"The 2007 WHO classification of tumours of the central nervous system","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. IARC, Lyon"},{"key":"401_CR32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/13547500902770090","volume":"14","author":"L Mariani","year":"2009","unstructured":"Mariani L, Miceli R, Michilin S, Gion M (2009) Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumour recurrences. Biomarkers 14:130\u2013136","journal-title":"Biomarkers"},{"key":"401_CR33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/003335490411900211","volume":"119","author":"K McDavid","year":"2004","unstructured":"McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD (2004) Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 119:174\u2013186","journal-title":"Public Health Rep"},{"key":"401_CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1006198422718","volume":"40","author":"M Nomura","year":"1998","unstructured":"Nomura M, Yamagishi S, Harada S, Yamashima T, Yamashita J, Yamamoto H (1998) Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 40:123\u2013130","journal-title":"J Neurooncol"},{"key":"401_CR35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500","journal-title":"N Engl J Med"},{"key":"401_CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0463.2007.apm_590.x","volume":"115","author":"I Pipp","year":"2007","unstructured":"Pipp I, Wagner L, Rossler K, Budka H, Preusser M (2007) Secretagogin expression in tumours of the human brain and its coverings. APMIS 115:319\u2013326","journal-title":"APMIS"},{"key":"401_CR37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00686391","volume":"76","author":"S Przedborski","year":"1988","unstructured":"Przedborski S, Goldman S, Schiffmann SN, Vierendeels G, Depierreux M, Levivier M, Hildebrand J, Vanderhaeghen JJ (1988) Neuropeptide Y, somatostatin, and cholecystokinin neurone preservation in anaplastic astrocytomas. Acta Neuropathol 76:507\u2013510","journal-title":"Acta Neuropathol"},{"key":"401_CR38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01454011","volume":"103","author":"M Rickmann","year":"1995","unstructured":"Rickmann M, Wolff JR (1995) Modifications of S100-protein immunoreactivity in rat brain induced by tissue preparation. Histochem Cell Biol 103:135\u2013145","journal-title":"Histochem Cell Biol"},{"key":"401_CR39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pneurobio.2008.09.006","volume":"86","author":"A Saavedra","year":"2008","unstructured":"Saavedra A, Baltazar G, Duarte EP (2008) Driving GDNF expression: the green and the red traffic lights. Prog Neurobiol 86:186\u2013215","journal-title":"Prog Neurobiol"},{"key":"401_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-2009-1146","volume":"18","author":"G Straten","year":"2009","unstructured":"Straten G, Eschweiler GW, Maetzler W, Laske C, Leyhe T (2009) Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls. J Alzheimers Dis 18:331\u2013337","journal-title":"J Alzheimers Dis"},{"key":"401_CR41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00441-003-0776-3","volume":"314","author":"M Tjwa","year":"2003","unstructured":"Tjwa M, Luttun A, Autiero M, Carmeliet P (2003) VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 314:5\u201314","journal-title":"Cell Tissue Res"},{"key":"401_CR42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cncr.21220","volume":"104","author":"MA Vogelbaum","year":"2005","unstructured":"Vogelbaum MA, Masaryk T, Mazzone P, Mekhail T, Fazio V, McCartney S, Marchi N, Kanner A, Janigro D (2005) S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. Cancer 104:817\u2013824","journal-title":"Cancer"},{"key":"401_CR43","doi-asserted-by":"crossref","first-page":"24740","DOI":"10.1074\/jbc.M001974200","volume":"275","author":"L Wagner","year":"2000","unstructured":"Wagner L, Oliyarnyk O, Gartner W, Nowotny P, Groeger M, Kaserer K, Waldhausl W, Pasternack MS (2000) Cloning and expression of secretagogin, a novel neuroendocrine- and pancreatic islet of Langerhans-specific Ca2+-binding protein. J Biol Chem 275:24740\u201324751","journal-title":"J Biol Chem"},{"key":"401_CR44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/PL00007416","volume":"99","author":"B Wiesenhofer","year":"2000","unstructured":"Wiesenhofer B, Stockhammer G, Kostron H, Maier H, Hinterhuber H, Humpel C (2000) Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas. Acta Neuropathol 99:131\u2013137","journal-title":"Acta Neuropathol"},{"key":"401_CR45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11060-009-9938-9","volume":"95","author":"A Wohrer","year":"2009","unstructured":"Wohrer A, Waldhor T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mosenbacher U, Kiefer A, Maier H, Motz R, Reiner-Concin A, Richling B, Idriceanu C, Scarpatetti M, Sedivy R, Bankl HC, Stiglbauer W, Preusser M, Rossler K, Hainfellner JA (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95:401\u2013411","journal-title":"J Neurooncol"},{"key":"401_CR46","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1523\/JNEUROSCI.10-11-03469.1990","volume":"10","author":"H Yamamoto","year":"1990","unstructured":"Yamamoto H, Gurney ME (1990) Human platelets contain brain-derived neurotrophic factor. J Neurosci 10:3469\u20133478","journal-title":"J Neurosci"},{"key":"401_CR47","first-page":"415","volume":"40","author":"Q Yan","year":"2009","unstructured":"Yan Q, Yu HL, Li JT (2009) Study on the expression of BDNF in human gliomas. Sichuan Da Xue Xue Bao Yi Xue Ban 40:415\u2013417","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-012-0401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-012-0401-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-012-0401-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:53:21Z","timestamp":1714132401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-012-0401-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1007\/s10143-012-0401-6","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}